Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study (Q34147296)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study |
scientific article |
Statements
1 reference
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study (English)
1 reference
M Goldberg
1 reference
Y-P Li
1 reference
J F Johanson
1 reference
A W Mangel
1 reference
M Kitt
1 reference
D T Beattie
1 reference
K Kersey
1 reference
O Daniels
1 reference
22 September 2010
1 reference
1 reference
32
1 reference
1102-1112
1 reference
Identifiers
1 reference
1 reference